Regeneron Pharmaceuticals, Inc.

SCOTIA CAPITAL INC. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

1,316

Value ($000)

1,016

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,016	0.0%	1,316	12/31/2025
2025 Q3	11/14/2025	637	0.0%	1,133	9/30/2025
2025 Q2	8/13/2025	596	0.0%	1,136	6/30/2025
2025 Q1	5/9/2025	717	0.0%	1,130	3/31/2025
2024 Q3	11/13/2024	1,132	0.0%	1,077	9/30/2024
2024 Q2	8/14/2024	470	0.0%	447	6/30/2024
2024 Q1	5/14/2024	417	0.0%	433	3/31/2024
2023 Q4	2/12/2024	361	0.0%	411	12/31/2023
2023 Q3	11/14/2023	242	0.0%	294	9/30/2023
2022 Q4	2/9/2023	276	0.0%	383	12/31/2022
2022 Q3	11/10/2022	265	0.0%	385	9/30/2022
2022 Q2	8/5/2022	250	0.0%	423	6/30/2022
2022 Q1	5/9/2022	237	0.0%	339	3/31/2022
2021 Q4	2/11/2022	2,738	0.0%	4,336	12/31/2021
2021 Q3	11/12/2021	2,577	0.0%	4,258	9/30/2021
2021 Q2	8/12/2021	4,152	0.0%	7,433	6/30/2021
2021 Q1	5/6/2021	4,729	0.0%	9,996	3/31/2021
2020 Q4	2/11/2021	4,809	0.0%	9,954	12/31/2020
2020 Q3	11/12/2020	4,915	0.1%	8,780	9/30/2020
2020 Q2	8/11/2020	4,901	0.1%	7,856	6/30/2020
2020 Q1	5/15/2020	3,143	0.0%	6,437	3/31/2020
2019 Q4	2/13/2020	210	0.0%	558	12/31/2019